Full View

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the …

DR Holmes, S Kar, MJ Price, B Whisenant… - Journal of the American …, 2014 - jacc.org
Abstract Background: In the PROTECT AF (Watchman Left Atrial Appendage Closure
Technology for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated …
被引用次数：1885 相关文章

Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The …

DR Holmes, S Kar, MJ Price… - Journal of the …, 2014 - providence.elsevierpure.com
BACKGROUND: In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology
for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with …

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the …

DR Holmes Jr, S Kar, MJ Price, B Whisenant, H Sievert… - 2014 - pubmed.ncbi.nlm.nih.gov
Background In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology for
Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with …

[引用][C] Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin …

DR Holmes, S Kar, MJ Price, B Whisenant… - Journal of the American …, 2014 - cir.nii.ac.jp
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure
Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy | CiNii …
[HTML] sciencedirect.com

[HTML][HTML] Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin …

DR Holmes Jr, S Kar, MJ Price, B Whisenant… - Journal of the American …, 2014 - Elsevier
Abstract Background In the PROTECT AF (Watchman Left Atrial Appendage Closure
Technology for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated …

Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The …

DR Holmes, S Kar, MJ Price… - Journal of the …, 2014 - mayoclinic.elsevierpure.com
BACKGROUND: In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology
for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with …

[引用][C] Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin …

DR HOLMES, S KAR, MJ PRICE… - Journal of the …, 2014 - pascal-francis.inist.fr
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure
Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy: The PREVAIL …

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the …

DR Holmes Jr, S Kar, MJ Price… - Journal of the …, 2014 - europepmc.org
Background In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology for
Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with …

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

DR Holmes, S Kar, MJ Price, B Whisenant… - Journal of the American …, 2014 - infona.pl
In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology for Embolic
Protection in Patients With Atrial Fibrillation) trial that evaluated patients with nonvalvular …

[引用][C] Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin …

DR Holmes, S Kar, MJ Price, B Whisenant… - Journal of the …, 2014 - Elsevier Limited